IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis
- Theranostics, Published: 2024.04.08; 14(6):2605-2621 | https://www.thno.org/v14p2605.htm